Implementation of a pertussis immunization program in a teaching hospital: An argument for federally mandated pertussis vaccination of health care workers

American Journal of Infection Control

Volumn 36, Issue 6, 2008, Pages 392-398

  Calderon, Melissa ^a   Feja, Kristina N ^a,b   Ford, Pat ^a   Frenkel, Lawrence D ^a,c   Gram, Amy ^a   Spector, Diane ^a   Tolan Jr , Robert W ^a,d  

^a SAINT PETER S UNIVERSITY HOSPITAL   (United States)

^b UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^c UNIVERSITY OF ILLINOIS   (United States)

^d DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; INFLUENZA VACCINE; PERTUSSIS VACCINE;

ARTICLE; DIPHTHERIA; DISEASE TRANSMISSION; EDUCATION PROGRAM; EMPLOYEE; HEALTH CARE PERSONNEL; HEALTH PROGRAM; HOSPITAL PERSONNEL; HUMAN; IMMUNIZATION; INFECTION CONTROL; INFLUENZA; MAJOR CLINICAL STUDY; PATIENT SAFETY; PERTUSSIS; TEACHING HOSPITAL; TETANUS;

CROSS INFECTION; DIPHTHERIA TOXOID; HEALTH PERSONNEL; HOSPITALS, TEACHING; HUMANS; IMMUNIZATION PROGRAMS; PERTUSSIS VACCINE; TETANUS TOXOID; TREATMENT OUTCOME; WHOOPING COUGH;

EID: 48049116559     PISSN: 01966553     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajic.2007.10.027     Document Type: Article

References (38)

1. Centers for Disease Control and Prevention (CDC). Pertussis-United States, 2001-2003. MMWR Morb Mortal Wkly Rep 54 (2005) 1283-1286
2. Kretsinger K., Broder K.R., Cortese M.M., Joyce M.P., Ortega-Sanchez I., Lee G.M., et al. Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel. MMWR Recomm Rep 55 RR-17 (2006 Dec 15) 1-37
3. Cherry J.D. Epidemiology of pertussis. Pediatr Infect Dis J 25 (2006) 361-362
4. Edwards K., and Freeman D.M. Adolescent and adult pertussis: disease burden and prevention. Curr Opin Pediatr 18 (2006) 77-80
5. Munoz F.M. Pertussis in infants, children, and adolescents: diagnosis, treatment, and prevention. Semin Pediatr Infect Dis 17 (2006) 14-19
6. Pichichero M.E., Blatter M.M., Kennedy W.A., Hedrick J., Descamps D., and Friedland L.R. Acellular pertussis vaccine booster combined with diphtheria and tetanus toxoids for adolescents. Pediatrics 117 (2006) 1084-1093
7. Wendelboe A.M., Van Rie A., Salmaso S., and Englund J.A. Duration of immunity against pertussis after natural infection or vaccination. Pediatr Infect Dis J 24 (2005) S58-S61
8. Stokley S., Santoli J.M., Willis B., Kelley V., Vargas-Rosales A., and Rodewald L.E. Impact of vaccine shortages on immunization programs and providers. Am J Prev Med 26 (2004) 15-21
9. Cherry J.D. The science and fiction of the "resurgence" of pertussis. Pediatrics 112 (2003) 405-406
10. Lievano F.A., Reynolds M.A., Waring A.L., Ackelsberg J., Bisgard K.M., Sanden G.N., et al. Issues associated with and recommendations for using PCR to detect outbreaks of pertussis. J Clin Microbiol 40 (2002) 2801-2805
11. Guris D., Strebel P.M., Bardenheier B., Brennan M., Tachdjian R., Finch E., et al. Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults, 1990-1996. Clin Infect Dis 28 (1999) 1230-1237
12. Yeh S.H., and Mink C.M. Shift in the epidemiology of pertussis infection: an indication for pertussis vaccine boosters for adults?. Drugs 66 (2006) 731-741
13. Vitek C.R., Pascual F.B., Baughman A.L., and Murphy T.V. Increase in deaths from pertussis among young infants in the United States in the 1990s. Pediatr Infect Dis J 22 (2003) 628-634
14. American Academy of Pediatrics Committee on Infectious Diseases. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine. Pediatrics 117 (2006) 965-978
15. Broder K.R., Cortese M.M., Iskander J.K., Kretsinger K., Slade B.A., Brown K.H., et al. Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 55 RR-3 (2006 Mar 24) 1-34
16. Food and Drug Administration. Product approval information-licensing action, package insert: tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine adsorbed ADACEL (sanofi pasteur, Rockville, MD): US Department of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research; 2005. Available at: http://www.fda.gov/cber/label/tdapave012306LB.pdf. Assessed February 27, 2007.
17. Food and Drug Administration. Product approval information-licensing action, package insert: BOOSTRIX. Tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, adsorbed. GlaxoSmithKline Biologicals, Rockville, MD: US Department of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research; 2005. Available at: http://www.fda.gov/cber/label/tdapgla122905LB.pdf. Assessed February 27, 2007.
18. Bamberger E., Starets-Haham O., Greenberg D., Karidis A., Porat N., Bar-Joseph G., et al. Adult pertussis hazardous for the newborn. Infect Control Hosp Epidemiol 27 (2006) 623-625
19. Bryant K.A., Humbaugh K., and Brothers K. Measures to control an outbreak of pertussis in a neonatal intermediate care nursery after exposure to a healthcare worker. Infect Control Hosp Epidemiol 27 (2006) 541-545
20. Centers for Disease Control and Prevention (CDC). Outbreaks of pertussis associated with hospitals-Kentucky, Pennsylvania, and Oregon, 2003. MMWR Morb Mortal Wkly Rep 54 (2005) 67-71
21. Christie C.D., Glover A.M., Willke M.J., Marx M.L., Reising S.F., and Hutchinson N.M. Containment of pertussis in the regional pediatric hospital during the Greater Cincinnati epidemic of 1993. Infect Control Hosp Epidemiol 16 (1995) 556-563
22. Fisher M.C., Long S.S., McGowan K.L., Kaselis E., and Smith D.G. Outbreak of pertussis in a residential facility for handicapped people. J Pediatr 114 (1989) 934-939
23. Matlow A.G., Nelson S., Wray R., and Cox P. Nosocomial acquisition of pertussis diagnosed by polymerase chain reaction. Infect Control Hosp Epidemiol 18 (1997) 715-716
24. Baggett H.C., Duchin J.S., Shelton W., Zerr D.M., Heath J., Ortega-Sanchez I.R., et al. Two nosocomial pertussis outbreaks and their associated costs-King County, Washington, 2004. Infect Control Hosp Epidemiol 28 (2007) 537-543
25. Calugar A., Ortega-Sanchez I.R., Tiwari T., Oakes L., Jahre J.A., and Murphy T.V. Nosocomial pertussis: costs of an outbreak and benefits of vaccinating health care workers. Clin Infect Dis 42 (2006) 981-988
26. Daskalaki I., Hennessey P., Hubler R., and Long S.S. Resource consumption in the infection control management of pertussis exposure among healthcare workers in pediatrics. Infect Control Hosp Epidemiol 28 (2007) 412-417
27. Zivna I., Bergin D., Casavant J., Fontecchio S., Nelson S., Kelley A., et al. Impact of Bordetella pertussis exposures on a Massachusetts tertiary care medical system. Infect Control Hosp Epidemiol 28 (2007) 708-712
28. Bisgard K.M., Pascual F.B., Ehresmann K.R., Miller C.A., Cianfrini C., Jennings C.E., et al. Infant pertussis: who was the source?. Pediatr Infect Dis J 23 (2004) 985-989
29. Boulay B.R., Murray C.J., Ptak J., Kirkland K.B., Montero J., and Talbot E.A. An outbreak of pertussis in a hematology-oncology care unit: implications for adult vaccination policy. Infect Control Hosp Epidemiol 27 (2006) 92-95
30. Centers for Disease Control and Prevention (CDC). Immunization of health-care workers: recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC). MMWR Recomm Rep 46 (1997) 1-42
31. Bolyard E.A., Tablan O.C., Williams W.W., Pearson M.L., Shapiro C.N., and Deitchmann S.D. Guideline for infection control in healthcare personnel, 1998. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 19 (1998) 407-463
32. Louther J., Feldman J., Rivera P., Villa N., DeHovitz J., and Sepkowitz K.A. Hepatitis B vaccination program at a New York City hospital: seroprevalence, seroconversion, and declination. Am J Infect Control 26 (1998) 423-427
33. Chodick G., Ashkenazi S., Livni G., and Lerman Y. Cost-effectiveness of varicella vaccination of healthcare workers. Vaccine 23 (2005) 5064-5072
34. Bryant K.A., Stover B., Cain L., Levine G.L., Siegel J., and Jarvis W.R. Improving influenza immunization rates among healthcare workers caring for high-risk pediatric patients. Infect Control Hosp Epidemiol 25 (2004) 912-917
35. Centers for Disease Control and Prevention (CDC). Interventions to increase influenza vaccination of health-care workers-California and Minnesota. MMWR Morb Mortal Wkly Rep 54 (2005) 196-199
36. King W.D., Woolhandler S.J., Brown A.F., Jiang L., Kevorkian K., Himmelstein D.U., et al. Brief report: influenza vaccination and health care workers in the United States. J Gen Intern Med 21 (2006) 181-184
37. Salgado C.D., Giannetta E.T., Hayden F.G., and Farr B.M. Preventing nosocomial influenza by improving the vaccine acceptance rate of clinicians. Infect Control Hosp Epidemiol 25 (2004) 923-928
38. Talbot T.R., Bradley S.E., Cosgrove S.E., Ruef C., Siegel J.D., and Weber D.J. Influenza vaccination of healthcare workers and vaccine allocation for healthcare workers during vaccine shortages. Infect Control Hosp Epidemiol 26 (2005) 882-890